305 related articles for article (PubMed ID: 28067172)
1. Fusing Docking Scoring Functions Improves the Virtual Screening Performance for Discovering Parkinson's Disease Dual Target Ligands.
Perez-Castillo Y; Helguera AM; Cordeiro MNDS; Tejera E; Paz-Y-Mino C; Sanchez-Rodriguez A; Borges F; Cruz-Monteagudo M
Curr Neuropharmacol; 2017 Nov; 15(8):1107-1116. PubMed ID: 28067172
[TBL] [Abstract][Full Text] [Related]
2. Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold.
Cruz-Monteagudo M; Borges F; Cordeiro MNDS; Helguera AM; Tejera E; Paz-Y-Mino C; Sanchez-Rodriguez A; Perera-Sardina Y; Perez-Castillo Y
Curr Neuropharmacol; 2017 Nov; 15(8):1117-1135. PubMed ID: 28093976
[TBL] [Abstract][Full Text] [Related]
3. Ligand-Based Virtual Screening Using Tailored Ensembles: A Prioritization Tool for Dual A2AAdenosine Receptor Antagonists / Monoamine Oxidase B Inhibitors.
Helguera AM; Perez-Castillo Y; D S Cordeiro MN; Tejera E; Paz-Y-Miño C; Sánchez-Rodríguez A; Teijeira M; Ancede-Gallardo E; Cagide F; Borges F; Cruz-Monteagudo M
Curr Pharm Des; 2016; 22(21):3082-96. PubMed ID: 26932160
[TBL] [Abstract][Full Text] [Related]
4. Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson's Disease.
Jaiteh M; Zeifman A; Saarinen M; Svenningsson P; Bréa J; Loza MI; Carlsson J
J Med Chem; 2018 Jun; 61(12):5269-5278. PubMed ID: 29792714
[TBL] [Abstract][Full Text] [Related]
5. Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies.
Załuski M; Schabikowski J; Schlenk M; Olejarz-Maciej A; Kubas B; Karcz T; Kuder K; Latacz G; Zygmunt M; Synak D; Hinz S; Müller CE; Kieć-Kononowicz K
Bioorg Med Chem; 2019 Apr; 27(7):1195-1210. PubMed ID: 30808606
[TBL] [Abstract][Full Text] [Related]
6. 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors.
Brunschweiger A; Koch P; Schlenk M; Rafehi M; Radjainia H; Küppers P; Hinz S; Pineda F; Wiese M; Hockemeyer J; Heer J; Denonne F; Müller CE
Bioorg Med Chem; 2016 Nov; 24(21):5462-5480. PubMed ID: 27658798
[TBL] [Abstract][Full Text] [Related]
7. Caffeine as a lead compound for the design of therapeutic agents for the treatment of Parkinson's disease.
Petzer JP; Petzer A
Curr Med Chem; 2015; 22(8):975-88. PubMed ID: 25544641
[TBL] [Abstract][Full Text] [Related]
8. Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B.
Kuder KJ; Załuski M; Schabikowski J; Latacz G; Olejarz-Maciej A; Jaśko P; Doroz-Płonka A; Brockmann A; Müller CE; Kieć-Kononowicz K
ChemMedChem; 2020 May; 15(9):772-786. PubMed ID: 32162782
[TBL] [Abstract][Full Text] [Related]
9. Binding mode similarity measures for ranking of docking poses: a case study on the adenosine A2A receptor.
Anighoro A; Bajorath J
J Comput Aided Mol Des; 2016 Jun; 30(6):447-56. PubMed ID: 27334985
[TBL] [Abstract][Full Text] [Related]
10. Selecting an optimal number of binding site waters to improve virtual screening enrichments against the adenosine A2A receptor.
Lenselink EB; Beuming T; Sherman W; van Vlijmen HW; IJzerman AP
J Chem Inf Model; 2014 Jun; 54(6):1737-46. PubMed ID: 24835542
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel and Selective Adenosine A
Tian S; Wang X; Li L; Zhang X; Li Y; Zhu F; Hou T; Zhen X
J Chem Inf Model; 2017 Jun; 57(6):1474-1487. PubMed ID: 28463561
[TBL] [Abstract][Full Text] [Related]
12. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
[TBL] [Abstract][Full Text] [Related]
13. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
[TBL] [Abstract][Full Text] [Related]
14. Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones.
Stössel A; Schlenk M; Hinz S; Küppers P; Heer J; Gütschow M; Müller CE
J Med Chem; 2013 Jun; 56(11):4580-96. PubMed ID: 23631427
[TBL] [Abstract][Full Text] [Related]
15. Novel approaches for targeting the adenosine A2A receptor.
Yuan G; Gedeon NG; Jankins TC; Jones GB
Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
[TBL] [Abstract][Full Text] [Related]
16.
Boulaamane Y; Ibrahim MAA; Britel MR; Maurady A
J Integr Bioinform; 2022 Dec; 19(4):. PubMed ID: 36112816
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the adenosine A
Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel dual adenosine A1/A2A receptor antagonists using deep learning, pharmacophore modeling and molecular docking.
Wang M; Hou S; Wei Y; Li D; Lin J
PLoS Comput Biol; 2021 Mar; 17(3):e1008821. PubMed ID: 33739970
[TBL] [Abstract][Full Text] [Related]
19. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
[TBL] [Abstract][Full Text] [Related]
20. Could the presence of sodium ion influence the accuracy and precision of the ligand-posing in the human A
Margiotta E; Deganutti G; Moro S
J Comput Aided Mol Des; 2018 Dec; 32(12):1337-1346. PubMed ID: 30361971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
